Screener
Organogenesis Holdings Inc. ORGO Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $406,446 | $598,730 |
| Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Equity | ||
| Current liabilities: | ||
| Current portion of finance lease obligations | $859 | $9,435 |
| Current portion of operating lease obligations - related party | 4,647 | 4,258 |
| Current portion of operating lease obligations | 3,807 | 4,949 |
| Accounts payable | 29,291 | 31,949 |
| Accrued expenses and other current liabilities | 18,359 | 49,533 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s current debt?
- Organogenesis Holdings Inc. (ORGO) reported current debt of $859K in Q2 2026.
- How has Organogenesis Holdings Inc.'s current debt changed year-over-year?
- Organogenesis Holdings Inc.'s current debt decreased by 29.4% year-over-year, from $1.22M to $859K.
- What is the long-term trend for Organogenesis Holdings Inc.'s current debt?
- Over 4 years (2020 to 2025), Organogenesis Holdings Inc.'s current debt has grown at a 27.1% compound annual growth rate (CAGR), from $3.62M to $9.44M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Organogenesis Holdings Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude